Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1105-1110
Published online before print May 15, 2003, doi: 10.1161/01.ATV.0000077206.35631.B2
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/6/1105    most recent
01.ATV.0000077206.35631.B2v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamashita, A.
Right arrow Articles by Sumiyoshi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamashita, A.
Right arrow Articles by Sumiyoshi, A.
Related Collections
Right arrow Animal models of human disease
Right arrow Arterial thrombosis
Right arrow Coagulation
Right arrow Platelet function inhibitors
Right arrow Platelets
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1105.)
© 2003 American Heart Association, Inc.


Thrombosis

Contribution of von Willebrand Factor to Thrombus Formation on Neointima of Rabbit Stenotic Iliac Artery Under High Blood-Flow Velocity

Atsushi Yamashita; Yujiro Asada; Hiroshi Sugimura; Hiroshi Yamamoto; Kousuke Marutsuka; Kinta Hatakeyama; Shozo Tamura; Yasuo Ikeda; Akinobu Sumiyoshi

From the First Department of Pathology (A.Y., Y.A., K.M., K.H., A.S.) and the Department of Radiology (H.S., S.T.), Miyazaki Medical College, Miyazaki; Pharmaceutical Research Laboratories (H.Y.), Ajinomoto Co, Inc, Kawasaki; and the Department of Medicine (Hematology) (Y.I.), Keio University School of Medicine, Tokyo, Japan.

Correspondence to Yujiro Asada, MD, First Department of Pathology, Miyazaki Medical College, 5200 Kihara, Kiyotake, Miyazaki 889-1692, Japan. E-mail yasada{at}fc.miyazaki-med.ac.jp

Objective— It has become clear that von Willebrand factor (vWF) plays important roles in platelet adhesion and aggregation under high blood-flow velocity conditions observed in stenotic atherosclerotic arteries. However, its roles in thrombus formation in vivo on diseased arteries have not been fully understood. We examined the contribution of vWF to thrombus formation and subsequent intimal growth by using a repeated balloon-injury model in rabbits.

Methods and Results— Rabbit iliac arteries 4 weeks after a first balloon injury showed 37% luminal stenosis by neointimal growth, and blood velocity increased by 2.1 times compared with that of uninjured arteries. The second balloon injury induced fibrin-rich thrombus formation on the injured neointima. Intravenous administration of a monoclonal antibody against vWF (AJW200, 1.0 mg/kg body weight) remarkably prevented botrocetin-induced platelet aggregation ex vivo for 2 days; moreover, thrombus formation, cell proliferation, and subsequent neointimal growth were significantly reduced at 30 minutes, 5 days, and 4 weeks, respectively, after the second balloon injury.

Conclusions— These results indicate that vWF plays a potent role in fibrin-rich thrombus formation on the neointima under high blood-flow velocity conditions. Inhibition of plasma vWF activity might be effective for the reduction of thrombus formation and/or subsequent neointimal development after coronary interventions.


Key Words: von Willebrand factor • thrombosis • blood flow • rabbits • AJW200




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
C. Lioupis, T. Kotsis, C. Barbatis, E. Seretis, A. Nomikos, I. Volondakis-Baltatzis, A. Papalois, V. Andrikopoulos, and D. Leaper
The Effect of Negative Pressure Therapy on the Femoral Vein Blood Flow and Wall Structure
Angiology, June 1, 2009; 60(3): 290 - 300.
[Abstract] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Yamashita, E. Furukoji, K. Marutsuka, K. Hatakeyama, H. Yamamoto, S. Tamura, Y. Ikeda, A. Sumiyoshi, and Y. Asada
Increased Vascular Wall Thrombogenicity Combined With Reduced Blood Flow Promotes Occlusive Thrombus Formation in Rabbit Femoral Artery
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2420 - 2424.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Gulati, D. Jevremovic, T. A. Witt, L. S. Kleppe, R. G. Vile, A. Lerman, and R. D. Simari
Modulation of the vascular response to injury by autologous blood-derived outgrowth endothelial cells
Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H512 - H517.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. F. W. Keuren, D. Baruch, P. Legendre, C. V. Denis, P. J. Lenting, J.-P. Girma, and T. Lindhout
Von Willebrand factor C1C2 domain is involved in platelet adhesion to polymerized fibrin at high shear rate
Blood, March 1, 2004; 103(5): 1741 - 1746.
[Abstract] [Full Text] [PDF]